KBC Group’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65K | Hold |
3,054
| – | – | ﹤0.01% | 1554 |
|
|
2025
Q4 | $65K | Buy |
+3,054
| New | +$62.6K | ﹤0.01% | 1533 |
|
|
2024
Q2 | – | Sell |
-3,098
| Closed | -$31K | – | 1886 |
|
|
2024
Q1 | $31K | Hold |
3,098
| – | – | ﹤0.01% | 1762 |
|
|
2023
Q4 | $29K | Hold |
3,098
| – | – | ﹤0.01% | 1815 |
|
|
2023
Q3 | $39K | Sell |
3,098
-3,728
| -55% | -$51.2K | ﹤0.01% | 1645 |
|
|
2023
Q2 | $97K | Hold |
6,826
| – | – | ﹤0.01% | 1197 |
|
|
2023
Q1 | $102K | Hold |
6,826
| – | – | ﹤0.01% | 1196 |
|
|
2022
Q4 | $101K | Hold |
6,826
| – | – | ﹤0.01% | 1191 |
|
|
2022
Q3 | $113K | Sell |
6,826
-1,141
| -14% | -$23K | ﹤0.01% | 1139 |
|
|
2022
Q2 | $167K | Buy |
+7,967
| New | +$163K | ﹤0.01% | 1040 |
|
|
2021
Q2 | – | Sell |
-37,282
| Closed | -$950K | – | 1302 |
|
|
2021
Q1 | $950K | Hold |
37,282
| – | – | ﹤0.01% | 883 |
|
|
2020
Q4 | $5.03M | Sell |
37,282
-2,236
| -6% | -$42K | ﹤0.01% | 854 |
|
|
2020
Q3 | $644K | Hold |
39,518
| – | – | ﹤0.01% | 877 |
|
|
2020
Q2 | $676K | Sell |
39,518
-78,944
| -67% | -$1.17M | ﹤0.01% | 893 |
|
|
2020
Q1 | $1.38M | Buy |
118,462
+28,983
| +32% | +$598K | 0.01% | 631 |
|
|
2019
Q4 | $2.49M | Hold |
89,479
| – | – | 0.02% | 630 |
|
|
2019
Q3 | $2.02M | Hold |
89,479
| – | – | 0.01% | 640 |
|
|
2019
Q2 | $2.26M | Buy |
89,479
+55,938
| +167% | +$1.5M | 0.02% | 582 |
|
|
2019
Q1 | $912K | Sell |
33,541
-75,639
| -69% | -$2.54M | 0.01% | 888 |
|
|
2018
Q4 | $3.6M | Sell |
109,180
-72,726
| -40% | -$2.92M | 0.04% | 407 |
|
|
2018
Q3 | $8.49M | Buy |
181,906
+177,286
| +3,837% | +$8.14M | 0.06% | 318 |
|
|
2018
Q2 | $200K | Sell |
4,620
-400
| -8% | -$19.2K | ﹤0.01% | 1142 |
|
|
2018
Q1 | $279K | Sell |
5,020
-4,290
| -46% | -$235K | ﹤0.01% | 1084 |
|
|
2017
Q4 | $498K | Sell |
9,310
-4,185
| -31% | -$197K | ﹤0.01% | 963 |
|
|
2017
Q3 | $582K | Sell |
13,495
-35,671
| -73% | -$1.7M | 0.01% | 937 |
|
|
2017
Q2 | $2.97M | Buy |
49,166
+35,784
| +267% | +$2.12M | 0.03% | 492 |
|
|
2017
Q1 | $928K | Buy |
13,382
+5,931
| +80% | +$412K | 0.01% | 887 |
|
|
2016
Q4 | $497K | Buy |
7,451
+1,910
| +34% | +$124K | ﹤0.01% | 1033 |
|
|
2016
Q3 | $367K | Sell |
5,541
-1,286
| -19% | -$88K | ﹤0.01% | 1032 |
|
|
2016
Q2 | $494K | Sell |
6,827
-2,990
| -30% | -$206K | 0.01% | 877 |
|
|
2016
Q1 | $635K | Sell |
9,817
-448
| -4% | -$29.7K | 0.01% | 772 |
|
|
2015
Q4 | $736K | Buy |
10,265
+4,196
| +69% | +$310K | 0.01% | 700 |
|
|
2015
Q3 | $466K | Buy |
+6,069
| New | +$490K | 0.01% | 789 |
|
Other funds holding MD
VPM
VCM
WA
KBC Group's MD Position: Q1 2026 in Review
KBC Group held its Pediatrix Medical (MD) position steady in Q1 2026 at 3,054 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #1554.
KBC Group first reported a position in MD in Q3 2015 and has held it in 33 quarters since. The position peaked at $8.49M in Q3 2018. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.
- KBC Group held 3,054 shares of Pediatrix Medical worth $65K as of Q1 2026.
- KBC Group left its Pediatrix Medical share count unchanged in Q1 2026.
- Pediatrix Medical made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1554 holding.
- KBC Group first reported a position in Pediatrix Medical in Q3 2015 and has held it in 33 quarters since.
- KBC Group's Pediatrix Medical position peaked at $8.49M in Q3 2018.
- 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.